Literature DB >> 18425139

Modeling lymphangiogenesis in a three-dimensional culture system.

Françoise Bruyère1, Laurence Melen-Lamalle, Silvia Blacher, Guy Roland, Marc Thiry, Lieve Moons, Francis Frankenne, Peter Carmeliet, Kari Alitalo, Claude Libert, Jonathan P Sleeman, Jean-Michel Foidart, Agnès Noël.   

Abstract

A lack of appropriate in vitro models of three-dimensional lymph vessel growth hampers the study of lymphangiogenesis. We developed a lymphatic ring assay--a potent, reproducible and quantifiable three-dimensional culture system for lymphatic endothelial cells that reproduces spreading of endothelial cells from a pre-existing vessel, cell proliferation, migration and differentiation into capillaries. In the assay, mouse thoracic duct fragments are embedded in a collagen gel, leading to the formation of lumen-containing lymphatic capillaries, which we assessed by electron microscopy and immunostaining. We developed a computerized method to quantify the lymphatic network. By applying this model to gene-deficient mice, we found evidence for involvement of the matrix metalloproteinase, MMP-2, in lymphangiogenesis. The lymphatic ring assay bridges the gap between two-dimensional in vitro models and in vivo models of lymphangiogenesis, can be used to exploit the potential of existing transgenic mouse models, and rapidly identify regulators of lymphangiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18425139     DOI: 10.1038/nmeth.1205

Source DB:  PubMed          Journal:  Nat Methods        ISSN: 1548-7091            Impact factor:   28.547


  46 in total

1.  Mouse corneal lymphangiogenesis model.

Authors:  Renhai Cao; Sharon Lim; Hong Ji; Yin Zhang; Yunlong Yang; Jennifer Honek; Eva-Maria Hedlund; Yihai Cao
Journal:  Nat Protoc       Date:  2011-05-19       Impact factor: 13.491

2.  Unimpeded skin carcinogenesis in K14-HPV16 transgenic mice deficient for plasminogen activator inhibitor.

Authors:  Anne Masset; Catherine Maillard; Nor Eddine Sounni; Nathalie Jacobs; Françoise Bruyére; Philippe Delvenne; Marlene Tacke; Thomas Reinheckel; Jean-Michel Foidart; Lisa M Coussens; Agnès Noël
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

3.  Macrophages define dermal lymphatic vessel calibre during development by regulating lymphatic endothelial cell proliferation.

Authors:  Emma J Gordon; Sujata Rao; Jeffrey W Pollard; Stephen L Nutt; Richard A Lang; Natasha L Harvey
Journal:  Development       Date:  2010-11       Impact factor: 6.868

Review 4.  Interaction between the extracellular matrix and lymphatics: consequences for lymphangiogenesis and lymphatic function.

Authors:  Helge Wiig; Doruk Keskin; Raghu Kalluri
Journal:  Matrix Biol       Date:  2010-08-18       Impact factor: 11.583

5.  VEGF-C induces lymphangiogenesis and angiogenesis in the rat mesentery culture model.

Authors:  Richard S Sweat; David C Sloas; Walter L Murfee
Journal:  Microcirculation       Date:  2014-08       Impact factor: 2.628

6.  State-of-the-Art Methods for Evaluation of Angiogenesis and Tissue Vascularization: A Scientific Statement From the American Heart Association.

Authors:  Michael Simons; Kari Alitalo; Brian H Annex; Hellmut G Augustin; Craig Beam; Bradford C Berk; Tatiana Byzova; Peter Carmeliet; William Chilian; John P Cooke; George E Davis; Anne Eichmann; M Luisa Iruela-Arispe; Eli Keshet; Albert J Sinusas; Christiana Ruhrberg; Y Joseph Woo; Stefanie Dimmeler
Journal:  Circ Res       Date:  2015-04-30       Impact factor: 17.367

7.  Human organotypic lymphatic vessel model elucidates microenvironment-dependent signaling and barrier function.

Authors:  Max M Gong; Karina M Lugo-Cintron; Bridget R White; Sheena C Kerr; Paul M Harari; David J Beebe
Journal:  Biomaterials       Date:  2019-05-25       Impact factor: 12.479

Review 8.  Fluorescent reporter transgenic mice for in vivo live imaging of angiogenesis and lymphangiogenesis.

Authors:  Susan J Doh; Michael Yamakawa; Samuel M Santosa; Mario Montana; Kai Guo; Joseph R Sauer; Nicholas Curran; Kyu-Yeon Han; Charles Yu; Masatsugu Ema; Mark I Rosenblatt; Jin-Hong Chang; Dimitri T Azar
Journal:  Angiogenesis       Date:  2018-07-03       Impact factor: 9.596

9.  Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro.

Authors:  Takeo Iwasaki; Yoshito Takeda; Kazuichi Maruyama; Yasuyuki Yokosaki; Kazuyuki Tsujino; Satoshi Tetsumoto; Hanako Kuhara; Kaori Nakanishi; Yasushi Otani; Yingji Jin; Satoshi Kohmo; Haruhiko Hirata; Ryo Takahashi; Mayumi Suzuki; Koji Inoue; Izumi Nagatomo; Sho Goya; Takashi Kijima; Toru Kumagai; Isao Tachibana; Ichiro Kawase; Atsushi Kumanogoh
Journal:  J Biol Chem       Date:  2012-12-05       Impact factor: 5.157

10.  Does plasminogen activator inhibitor-1 drive lymphangiogenesis?

Authors:  Françoise Bruyère; Laurence Melen-Lamalle; Silvia Blacher; Benoît Detry; Anne Masset; Julie Lecomte; Vincent Lambert; Catherine Maillard; Gunilla Høyer-Hansen; Leif R Lund; Jean-Michel Foidart; Agnès Noël
Journal:  PLoS One       Date:  2010-03-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.